Infinity Pharmaceuticals, Inc. (INFI) financial statements (2022 and earlier)

Company profile

Business Address 1100 MASSACHUSETTS AVENUE
CAMBRIDGE, MA 02138
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments80,72634,10842,44458,59157,60992,064245,231
Cash and cash equivalents80,72628,59322,26048,61634,60774,060188,170
Short-term investments 5,51520,1849,97523,00218,00457,061
Restricted cash and investments 150   1,152 
Receivables     851,185
Prepaid expense1,1431,5281,6806415633,3366,898
Other current assets3992344575862145,0231,383
Total current assets:82,26836,02044,58159,81858,386101,660254,697
Noncurrent Assets
Operating lease, right-of-use asset1,0641,4191,717
Property, plant and equipment1,2411,7102,1862821923,42428,240
Restricted cash and investments158165315  5301,681
Other noncurrent assets545215369748412,382
Other undisclosed noncurrent assets      1,821
Total noncurrent assets:2,5173,2994,43339796723,99534,124
TOTAL ASSETS:84,78539,31949,01460,21559,353125,655288,821
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities13,30011,0479,6987,7185,59523,42134,232
Accounts payable2,3202,9821,6211,1974592,4139,628
Accrued liabilities10,9808,0658,0776,5215,13621,00824,604
Debt    6,000  
Deferred revenue and credits  35,408
Other undisclosed current liabilities     442416
Total current liabilities:13,30011,0479,6987,71811,59523,86370,056
Noncurrent Liabilities
Long-term debt and lease obligation9171,4361,926    
Operating lease, liability9171,4361,926
Liabilities, other than long-term debt270245383828189100,617
Deferred revenue and credits 183100,163
Other liabilities2702453838286454
Other undisclosed noncurrent liabilities48,72749,58029,626  19,14919,591
Total noncurrent liabilities:49,91451,26131,590382819,338120,208
Total liabilities:63,21462,30841,2887,75611,62343,201190,264
Stockholders' equity
Stockholders' equity attributable to parent21,571(22,989)7,72652,45947,73082,45498,557
Common stock89645757515049
Additional paid in capital833,065743,269733,486731,178715,213708,096694,051
Accumulated other comprehensive income (loss) (1)12(4)(15)(3)45
Accumulated deficit(811,583)(766,321)(725,829)(678,772)(667,519)(625,689)(595,588)
Total stockholders' equity:21,571(22,989)7,72652,45947,73082,45498,557
TOTAL LIABILITIES AND EQUITY:84,78539,31949,01460,21559,353125,655288,821

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues1,8581,7193,04922,1466,00018,723109,066
Revenue, net6,00018,723109,066
Cost of revenue
(Cost of Goods and Services Sold)
      (23,000)
Gross profit:1,8581,7193,04922,1466,00018,72386,066
Operating expenses(46,941)(40,216)(48,713)(34,075)(42,445)(161,830)(236,174)
Other undisclosed operating income     112,21623,000
Operating loss:(45,083)(38,497)(45,664)(11,929)(36,445)(30,891)(127,108)
Nonoperating income (expense)(179)(1,995)(1,447)676(6,105)790(933)
Investment income, nonoperating  1,116    
Other nonoperating income1450 7691,7872,015435
Interest and debt expense(180)(153)(2,563)(93)(1,010)(1,225)(1,368)
Other undisclosed income from continuing operations before equity method investments, income taxes 1532,563931,0101,2251,368
Loss from continuing operations before income taxes:(45,442)(40,492)(47,111)(11,253)(42,550)(30,101)(128,041)
Income tax expense (benefit)  54 720 (335)
Net loss:(45,442)(40,492)(47,057)(11,253)(41,830)(30,101)(128,376)
Other undisclosed net income attributable to parent180      
Net loss available to common stockholders, diluted:(45,262)(40,492)(47,057)(11,253)(41,830)(30,101)(128,376)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(45,442)(40,492)(47,057)(11,253)(41,830)(30,101)(128,376)
Comprehensive loss:(45,442)(40,492)(47,057)(11,253)(41,830)(30,101)(128,376)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent181(13)1611(12)(48)(69)
Comprehensive loss, net of tax, attributable to parent:(45,261)(40,505)(47,041)(11,242)(41,842)(30,149)(128,445)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: